Bactiquant AS (BACTIQ) - Net Assets
Based on the latest financial reports, Bactiquant AS (BACTIQ) has net assets worth Dkr17.26 Million DKK (≈ $2.70 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Dkr28.07 Million ≈ $4.39 Million USD) and total liabilities (Dkr10.81 Million ≈ $1.69 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See Bactiquant AS balance sheet independence to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Dkr17.26 Million |
| % of Total Assets | 61.5% |
| Annual Growth Rate | 5.35% |
| 5-Year Change | -18.05% |
| 10-Year Change | N/A |
| Growth Volatility | 844.84 |
Bactiquant AS - Net Assets Trend (2018–2025)
This chart illustrates how Bactiquant AS's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Bactiquant AS market cap and net worth.
Annual Net Assets for Bactiquant AS (2018–2025)
The table below shows the annual net assets of Bactiquant AS from 2018 to 2025. Also explore BACTIQ net assets growth trend to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Dkr17.26 Million ≈ $2.70 Million |
+2404.32% |
| 2024-12-31 | Dkr689.23K ≈ $107.84K |
-95.22% |
| 2023-12-31 | Dkr14.41 Million ≈ $2.25 Million |
+0.74% |
| 2022-12-31 | Dkr14.31 Million ≈ $2.24 Million |
-32.08% |
| 2021-12-31 | Dkr21.06 Million ≈ $3.30 Million |
+134.90% |
| 2020-12-31 | Dkr8.97 Million ≈ $1.40 Million |
-17.18% |
| 2019-12-31 | Dkr10.83 Million ≈ $1.69 Million |
-9.69% |
| 2018-12-31 | Dkr11.99 Million ≈ $1.88 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Bactiquant AS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 231.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Dkr14.06 Million | 81.48% |
| Common Stock | Dkr1.88 Million | 10.87% |
| Other Comprehensive Income | Dkr1.32 Million | 7.65% |
| Total Equity | Dkr17.26 Million | 100.00% |
Bactiquant AS Competitors by Market Cap
The table below lists competitors of Bactiquant AS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sheffield Resources Ltd
AU:SFX
|
$12.33 Million |
|
NTG Clarity Networks Inc.
V:NCI
|
$12.33 Million |
|
BBGI SICAV SA
LSE:BBGI
|
$12.33 Million |
|
Glimpse Group Inc
NASDAQ:VRAR
|
$12.35 Million |
|
B+S Banksysteme Aktiengesellschaft
F:DTD2
|
$12.33 Million |
|
Kingfish Company Nv
OL:KING
|
$12.31 Million |
|
Capital Engineering Network Public Company Limited
BK:CEN
|
$12.31 Million |
|
Regenbogen AG
F:RGB
|
$12.30 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bactiquant AS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 689,233 to 17,260,615, a change of 16,571,382 (2404.3%).
- Net loss of 13,833,117 reduced equity.
- New share issuances of 30,985,928 increased equity.
- Other comprehensive income increased equity by 330,785.
- Other factors decreased equity by 912,214.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Dkr-13.83 Million | -80.14% |
| Share Issuances | Dkr30.99 Million | +179.52% |
| Other Comprehensive Income | Dkr330.79K | +1.92% |
| Other Changes | Dkr-912.21K | -5.28% |
| Total Change | Dkr- | 2404.32% |
Book Value vs Market Value Analysis
This analysis compares Bactiquant AS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.62x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 3.23x to 3.62x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | Dkr0.65 | Dkr2.10 | x |
| 2019-12-31 | Dkr0.59 | Dkr2.10 | x |
| 2020-12-31 | Dkr0.62 | Dkr2.10 | x |
| 2021-12-31 | Dkr1.11 | Dkr2.10 | x |
| 2022-12-31 | Dkr0.73 | Dkr2.10 | x |
| 2023-12-31 | Dkr0.70 | Dkr2.10 | x |
| 2024-12-31 | Dkr0.03 | Dkr2.10 | x |
| 2025-12-31 | Dkr0.58 | Dkr2.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bactiquant AS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -80.14%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -166.29%
- • Asset Turnover: 0.30x
- • Equity Multiplier: 1.63x
- Recent ROE (-80.14%) is above the historical average (-293.59%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | -9.69% | -21.46% | 0.37x | 1.23x | Dkr-2.36 Million |
| 2019 | -2.52% | -4.83% | 0.41x | 1.26x | Dkr-1.36 Million |
| 2020 | -10.95% | -17.91% | 0.51x | 1.19x | Dkr-1.88 Million |
| 2021 | -64.34% | -162.12% | 0.34x | 1.16x | Dkr-15.66 Million |
| 2022 | -99.15% | -114.50% | 0.53x | 1.62x | Dkr-15.62 Million |
| 2023 | -90.92% | -106.51% | 0.48x | 1.77x | Dkr-14.55 Million |
| 2024 | -1990.99% | -191.25% | 0.49x | 21.32x | Dkr-13.79 Million |
| 2025 | -80.14% | -166.29% | 0.30x | 1.63x | Dkr-15.56 Million |
Industry Comparison
This section compares Bactiquant AS's net assets metrics with peer companies in the Pollution & Treatment Controls industry.
No peer company data available for comparison.
About Bactiquant AS
BactiQuant A/S develops, produces, and provides technology for the mobile and online surveillance of bacterial contamination levels in water. The company offers Mobile Lab, a handheld tool for pollution tracking; BQ Online 2.0 PRO, an online solution to quantify the bacteria in water systems; and a range of analysis kits to monitor water quality. It serves various industries in the areas of aquac… Read more